1Yeomans N,Lanas A,Labenz J,et at.Efficacy of esomeprazole(20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin. The American journal of Gastroenterology . 2008
2Chan FK.Long-term incidence of ulcer bleeding with low-dose aspirin after eradication of H pylori:A 4- year prospective cohort study. Gastroenterology . 2005
3Ng FH,Wong SY,Chang CM,et al.High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease. Alimentary Pharmacology and Therapeutics . 2003
4Aubert RE,Epstein RS,Teagarden JR,et al.Understanding variability in antiplatelet drug effects in acute coronary syndromes.Abstract 3998:proton pump inhibitors effect on clopidogrel effectiveness:the clopidogrel medco outcomes study. Circulation . 2008
5Sheikh RA,Romano PS,Prindiville TP,et al.Endoscopic evidence of mucosal injury in patients taking ticlopidine compared with patients taking aspirin/nonsteroidal antiinflammatory drugs and controls. Journal of Clinical Gastroenterology . 2002
6Pezalla E,Day D.Initial assessment of clinical i mpact of a druginteraction between clopidogrel and proton pump inhibitors. Journal of the American College of Cardiology . 2008
7B Cryer,M Feldman.Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology . 1999
8F Feit,MD Voeltz,MJ Attubato.Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention: an analysis of the REPLACE-2 trial. The American Journal of Cardiology . 2007
9F.K. Chan,S.C. Chung,B.Y. Suen.Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. The New England Journal of Medicine . 2001
10Bhatt DL,Scheiman J,Abraham NS,et al.ACCF/ACG/AHA2008expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use:a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Doc-uments. J Am Coll Circulation . 2008
2Steinhubl SR,Berger PB,Mann JT III,et al.Clopidogrel for the Reductionof Events During Observation.Early and sustained dual oral anti-platelet therapyfollowing percutaneous coronary intervention:arandomized controlled trial(CREDO)[J].JAMA,2002,288(19):2411-2420.
3Bj?rklund L,Wallander M-A,Johansson S,Lesén E.Aspirin in cardiology--benefits and risks. International journal of clinical practice . 2009
